Biomarker has future applications in new drug candidate identification and could be used in broader cardiovascular and aging-related research. PEABODY, Mass., March 15, 2023 (Newswire.com) - A newly ...
PEABODY, Mass. & COLUMBUS, Ohio, March 03, 2026--(BUSINESS WIRE)--The Progeria Research Foundation ("PRF"), a nonprofit research organization dedicated to developing treatments and the cure for ...
A University of Maryland-led discovery could spur the development of new and improved treatments for Hutchinson-Gilford progeria syndrome (HGPS), a rare genetic disorder with no known cure that causes ...
PALO ALTO, Calif., Dec. 3, 2018 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for rare and ultra-rare diseases, ...
The results of a University of Maryland (UMD)-led study could point to new and improved treatment approaches for Hutchinson-Gilford progeria syndrome (HGPS), a rare genetic disorder that causes ...
Hutchinson-Gilford progeria syndrome (HGPS) is an extremely rare genetic disease that affects just 1 in every 20 million people; it is estimated that fewer than 400 children in the world have the ...
Add Yahoo as a preferred source to see more of our stories on Google. Sammy Basso at the start of 2022 Venice Marathon, in which he competed alongside 30 supporters - Alessio Marini/LPS via ZUMA Press ...
One of about 150 people known to have a rare condition that causes rapid aging, he sought to raise awareness and participated in the search for a cure. By Trip Gabriel Sammy Basso, an advocate for ...
PEABODY — The Progeria Research Foundation’s annual Race for Research will celebrate 25 years of raising money for a cure when runners and walkers take off in Peabody on Sept. 19. Hutchinson-Gilford ...
A ground-breaking online community has been launched to allow people with the rare disease Progeria to communicate regardless of their location or language. Progeria Connect, a new partnership between ...
PEABODY, MA / ACCESSWIRE / March 15, 2023 / A newly developed progerin biomarker indicates long-term benefit of treatment in children with Progeria is greater than previously determined, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results